» Authors » Tejal Joshi

Tejal Joshi

Explore the profile of Tejal Joshi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 834
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Piparva K, Fichadiya N, Joshi T, Malek S
Cureus . 2024 May; 16(4):e58866. PMID: 38800170
Monkeypox is a zoonotic viral disease. Monkeypox was first reported in humans about 54 years ago. Prior to the global outbreak, monkeypox was endemic to the rainforests of central and...
2.
Bhat S, Prasannakumar C, Joshi T
Indian J Thorac Cardiovasc Surg . 2023 Feb; 39(2):211-215. PMID: 36785600
Supplementary Information: The online version contains supplementary material available at 10.1007/s12055-023-01476-w.
3.
Hansen T, Mollerup S, Nguyen N, White N, Coghlan M, Alquezar-Planas D, et al.
Emerg Microbes Infect . 2016 Aug; 5(8):e90. PMID: 27530749
Outbreaks of zoonotic diseases in humans and livestock are not uncommon, and an important component in containment of such emerging viral diseases is rapid and reliable diagnostics. Such methods are...
4.
Joshi T, Elias D, Stenvang J, Alves C, Teng F, Lyng M, et al.
Oncotarget . 2016 Aug; 7(35):57239-57253. PMID: 27528030
Tamoxifen is an effective anti-estrogen treatment for patients with estrogen receptor-positive (ER+) breast cancer, however, tamoxifen resistance is frequently observed. To elucidate the underlying molecular mechanisms of tamoxifen resistance, we...
5.
Polur H, Joshi T, Workman C, Lavekar G, Kouskoumvekaki I
Mol Inform . 2016 Jul; 30(2-3):181-7. PMID: 27466772
Ayurveda, the traditional Indian medicine is one of the most ancient, yet living medicinal traditions. In the present work, we developed an in silico library of natural products from Ayurveda...
6.
Hansen T, Joshi T, Larsen A, Andersen P, Harms K, Mollerup S, et al.
Evol Med Public Health . 2016 Jul; 2016(1):219-26. PMID: 27412864
Background And Objectives: Widespread use of antibiotics has resulted in selection pressure on genes that make bacteria non-responsive to antibiotics. These antibiotic-resistant bacteria are currently a major threat to global...
7.
Marquard A, Eklund A, Joshi T, Krzystanek M, Favero F, Wang Z, et al.
Biomark Res . 2015 May; 3:9. PMID: 26015868
Background: Ovarian and triple-negative breast cancers with BRCA1 or BRCA2 loss are highly sensitive to treatment with PARP inhibitors and platinum-based cytotoxic agents and show an accumulation of genomic scars...
8.
Gulati S, Martinez P, Joshi T, Birkbak N, Santos C, Rowan A, et al.
Eur Urol . 2014 Jul; 66(5):936-48. PMID: 25047176
Background: Candidate biomarkers have been identified for clear cell renal cell carcinoma (ccRCC) patients, but most have not been validated. Objective: To validate published ccRCC prognostic biomarkers in an independent...
9.
Re A, Joshi T, Kulberkyte E, Morris Q, Workman C
Methods Mol Biol . 2014 Mar; 1097:491-521. PMID: 24639174
RNA binding proteins (RBPs) are key players in the regulation of gene expression. In this chapter we discuss the main protein-RNA recognition modes used by RBPs in order to regulate...
10.
Dewhurst S, McGranahan N, Burrell R, Rowan A, Gronroos E, Endesfelder D, et al.
Cancer Discov . 2014 Jan; 4(2):175-185. PMID: 24436049
Unlabelled: The contribution of whole-genome doubling to chromosomal instability (CIN) and tumor evolution is unclear. We use long-term culture of isogenic tetraploid cells from a stable diploid colon cancer progenitor...